why choose us

First received: November 21, 2024

Clinical Trial: A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Type 2 Diabetes

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Randomized, Open-label, Controlled Study on Evaluating the Efficacy and Safety of Switching From Daily DPP-4 Inhibitors to HSK7653 Tablets in Patients With Type 2 Diabetes Mellitus in C

Brief Summary: To assess the effectiveness of HSK7653 tablets following the substitution of daily DPP-4 inhibitor (DPP-4i) over a 24-week treatment period.

Read more